Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22694,175,1.16 [0.95-1.40],0.1386995918993507
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23734,190,1.05 [0.87-1.26],0.6329702229304035
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23486,1411,1.10 [1.03-1.18],0.0044766299346094
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23746,379,1.09 [0.95-1.24],0.2055296791977902
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23054,3467,1.08 [1.04-1.13],0.0003117730759586
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23009,3495,1.11 [1.06-1.16],2.9229514202574685e-06
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23531,1039,1.11 [1.03-1.20],0.0096200331682257
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23667,80,0.83 [0.62-1.12],0.2263875581601753
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21522,1125,1.15 [1.06-1.24],0.0005117860490116
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20767,1243,1.21 [1.13-1.30],1.483717039044002e-07
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,20481,251,1.33 [1.13-1.55],0.000453431076296
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16713,2277,1.12 [1.06-1.18],3.2891386577686035e-05
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20414,405,1.23 [1.08-1.40],0.0013184745231632
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23736,1244,1.09 [1.01-1.17],0.0273507750156469
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Mycoses,23837,470,1.11 [0.99-1.25],0.0706030537264317
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22967,892,1.11 [1.02-1.21],0.0192738312906894
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23757,1238,1.11 [1.04-1.20],0.0036934340768412
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22684,192,1.06 [0.88-1.27],0.5605252694498982
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23875,54,1.03 [0.73-1.47],0.8599668454749725
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23603,1084,1.12 [1.04-1.21],0.0036546432214034
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23658,71,1.01 [0.74-1.38],0.9455501319282608
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23812,120,0.94 [0.74-1.19],0.6153113242563809
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23793,101,1.01 [0.78-1.31],0.948400362480081
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22568,493,1.16 [1.03-1.30],0.0126876125231166
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22362,287,1.18 [1.01-1.37],0.0328629536422668
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22581,89,1.17 [0.89-1.53],0.2600240843907552
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23856,68,1.05 [0.77-1.43],0.7530572998436705
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23821,146,1.06 [0.85-1.31],0.596867613545042
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Viral warts,23728,53,0.96 [0.67-1.38],0.8364425312334626
CPA2,Carboxypeptidase A2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23727,52,1.08 [0.75-1.54],0.6878517658909116
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign lipomatous neoplasm,23557,341,1.03 [0.90-1.19],0.6392872336235322
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23803,44,1.03 [0.69-1.53],0.8970682788234318
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23768,55,0.86 [0.60-1.24],0.4307987141642533
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23827,128,0.98 [0.77-1.23],0.8396321711940491
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23500,1640,1.02 [0.96-1.09],0.5736749618954478
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign neoplasm of meninges,23875,32,0.95 [0.59-1.51],0.8174617847021813
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23811,63,1.08 [0.78-1.50],0.6293117636973682
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23860,76,1.03 [0.77-1.39],0.8379130244382816
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23850,443,1.09 [0.96-1.23],0.1724354482801684
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign neoplasm: Caecum,23845,338,1.03 [0.89-1.18],0.6983242815965957
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23744,80,0.84 [0.62-1.14],0.2602465099564078
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23843,278,0.97 [0.83-1.13],0.6771405461603894
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign neoplasm: Rectum,23801,420,0.98 [0.87-1.12],0.8041274428989595
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23751,728,0.97 [0.88-1.07],0.503261449921715
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23832,560,1.01 [0.90-1.12],0.9197944286714628
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",18544,71,0.91 [0.66-1.25],0.5579997361809186
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",18544,71,0.95 [0.69-1.30],0.7488461599459116
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23843,100,1.11 [0.86-1.44],0.4223879121380023
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Haemangioma, any site",23843,97,1.13 [0.87-1.47],0.351966001484622
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Lung cancer and mesothelioma,15888,344,0.85 [0.74-0.99],0.0312692830881004
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Lymphoid leukaemia,18538,65,1.00 [0.72-1.39],0.9996222344455028
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18675,202,1.08 [0.90-1.30],0.4102166930316333
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",18766,293,1.08 [0.93-1.26],0.2989981941431577
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",18564,91,1.25 [0.97-1.62],0.0885705680339237
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",18616,143,1.20 [0.97-1.48],0.0915455368940459
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",18611,138,1.04 [0.84-1.29],0.7295179285952771
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",18555,82,1.40 [1.06-1.83],0.0160684481633756
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19875,1402,1.00 [0.93-1.07],0.9307491077802426
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",18616,143,0.85 [0.68-1.06],0.1496600350407926
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",18578,105,0.98 [0.76-1.27],0.8927753562592818
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,18604,131,0.97 [0.76-1.22],0.7667380590617774
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Melanocytic naevi,23748,169,0.83 [0.67-1.02],0.0721587042088729
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Melanocytic naevi of trunk,23844,93,0.81 [0.61-1.07],0.1376770634784634
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Melanoma in situ,18507,74,1.10 [0.81-1.49],0.5449791967442197
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",18573,100,0.99 [0.76-1.28],0.9137085764683912
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18643,170,1.16 [0.96-1.42],0.1274581378779648
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18692,219,0.93 [0.78-1.11],0.4366186620838342
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",18577,104,0.97 [0.75-1.25],0.7939409455371174
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,Other benign neoplasms of skin,23741,138,1.02 [0.82-1.27],0.8734090646184491
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19682,1209,1.01 [0.94-1.09],0.8177784780949771
CPA2,Carboxypeptidase A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19760,1287,1.02 [0.95-1.10],0.5757776267278678
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23602,310,0.94 [0.81-1.10],0.451076462403657
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22136,119,1.52 [1.22-1.90],0.000211884695804
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23364,72,1.50 [1.13-2.00],0.0049575728795364
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23314,2786,1.14 [1.08-1.19],2.311558683120806e-07
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22600,60,0.89 [0.64-1.26],0.5201419894916006
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23449,54,0.99 [0.69-1.41],0.9567106331894668
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23495,1478,1.17 [1.10-1.25],3.106203749307944e-06
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23493,1476,1.17 [1.09-1.25],4.257460132928858e-06
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22122,105,1.16 [0.90-1.49],0.2409743024857049
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23640,1100,1.23 [1.14-1.32],1.5772759905388958e-07
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23500,105,0.92 [0.71-1.19],0.5421441844950485
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23366,74,0.87 [0.64-1.17],0.3506083895674958
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23352,60,0.92 [0.65-1.29],0.6225107256562087
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23712,317,1.01 [0.87-1.17],0.9203588958727096
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23778,49,1.38 [0.97-1.96],0.0750974834666557
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23652,257,1.00 [0.85-1.18],0.988091668695241
CPA2,Carboxypeptidase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22616,76,1.03 [0.76-1.38],0.8668919712265126
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,17596,373,1.22 [1.07-1.39],0.003355666802628
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21832,164,0.84 [0.68-1.03],0.0862618315302886
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21859,191,0.96 [0.79-1.17],0.6927372957796794
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,17280,57,0.92 [0.65-1.32],0.6639465025317259
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22500,65,1.28 [0.95-1.74],0.1094808371779094
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21736,222,1.23 [1.04-1.45],0.0182944067017919
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23370,615,1.05 [0.94-1.17],0.3681460733965577
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22994,239,1.07 [0.91-1.27],0.4053895286732113
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22923,168,0.98 [0.80-1.20],0.8470371005747669
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23573,1138,1.00 [0.93-1.08],0.9787156949410069
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20428,1096,0.99 [0.91-1.07],0.7962578948803862
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",17298,75,1.45 [1.09-1.92],0.0097947933144129
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22996,40,0.94 [0.62-1.43],0.7762191301039121
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,17499,276,1.19 [1.02-1.39],0.024429164645476
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,17295,72,0.84 [0.61-1.15],0.2805673485319117
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21106,3883,1.11 [1.06-1.15],1.8085522632988208e-06
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,17408,185,1.15 [0.96-1.39],0.1375803142456671
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17790,567,1.07 [0.96-1.20],0.2078726500312288
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23816,278,1.11 [0.95-1.29],0.2037458670233928
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23629,91,1.72 [1.35-2.20],1.225075572932415e-05
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,17375,152,0.96 [0.77-1.19],0.6897903657286537
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",17288,65,1.10 [0.80-1.51],0.577568708474739
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23696,740,0.99 [0.90-1.10],0.916569653218052
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17529,306,1.31 [1.14-1.51],0.0001799064125645
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17603,380,1.46 [1.28-1.65],3.732322305212943e-09
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17951,728,1.08 [0.98-1.19],0.1235098518822629
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,17368,145,1.04 [0.84-1.29],0.7097376724213962
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23622,84,1.62 [1.25-2.10],0.0002461629791896
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17789,566,1.02 [0.91-1.14],0.7763983482005169
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17613,390,0.91 [0.80-1.04],0.1767284296318611
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21581,67,1.49 [1.11-2.01],0.0088766125488728
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22432,5209,1.07 [1.03-1.11],0.0003667851680813
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22975,19,1.42 [0.81-2.50],0.2186378527397632
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22978,22,1.32 [0.78-2.24],0.2921094139378797
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23705,1774,1.05 [0.99-1.11],0.1147927342182928
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23702,1770,1.05 [0.99-1.11],0.109672524440707
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22979,23,1.50 [0.92-2.45],0.1018870393326417
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23604,802,0.99 [0.90-1.09],0.8327728755886108
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18840,1617,1.09 [1.02-1.16],0.0077872747272664
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23864,263,1.69 [1.47-1.95],3.7076616913716804e-13
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22864,109,1.14 [0.89-1.46],0.2993521151568932
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22877,75,1.21 [0.90-1.61],0.2012037627785512
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22883,81,1.11 [0.84-1.48],0.463656761472345
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",17289,66,1.10 [0.79-1.51],0.5753140135914511
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21086,167,2.12 [1.77-2.54],5.536093534674073e-16
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2509,123,1.37 [1.14-1.67],0.0011122447521345
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2671,318,1.58 [1.40-1.78],3.9357045709924054e-14
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,21020,101,2.31 [1.84-2.90],7.461433878625222e-13
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2466,82,1.79 [1.42-2.27],1.342878127290388e-06
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23087,2168,1.40 [1.33-1.48],2.890796063492236e-34
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23114,359,0.99 [0.86-1.14],0.9133056262900336
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21755,241,1.30 [1.11-1.53],0.0011544040521922
CPA2,Carboxypeptidase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,18024,801,1.22 [1.12-1.34],9.92536652597731e-06
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23749,252,0.97 [0.82-1.14],0.7093786612854667
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22642,271,0.91 [0.77-1.07],0.2361968752083675
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Angina pectoris,20956,1505,1.05 [0.99-1.13],0.1199785622830729
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22754,383,0.92 [0.80-1.05],0.1987926067805253
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22455,84,1.30 [0.99-1.70],0.0544696887790362
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22618,247,1.27 [1.08-1.48],0.00317673902577
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,13980,2315,1.02 [0.96-1.08],0.4976158239410961
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,AV-block,19202,621,1.19 [1.07-1.32],0.0010740285261716
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23801,540,1.01 [0.90-1.13],0.9126500302568264
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Cardiac arrest,11916,251,1.15 [0.98-1.36],0.0869218118832044
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18780,199,0.97 [0.81-1.17],0.7766039793023192
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",18689,108,1.17 [0.91-1.50],0.211462897604931
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23876,67,1.33 [0.98-1.79],0.0644220158295506
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Conduction disorders,19942,1361,1.13 [1.05-1.21],0.0006098199040759
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22057,2629,1.07 [1.02-1.13],0.0085632702823351
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20111,7778,1.04 [1.01-1.07],0.0201764817369985
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22637,276,0.94 [0.80-1.10],0.4516046608599824
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Endocarditis,18664,83,1.20 [0.91-1.60],0.2010947142861582
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23564,1328,1.12 [1.05-1.20],0.0012390506351387
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Hypertension,21313,6776,1.06 [1.03-1.10],0.0001876976673393
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21336,6799,1.06 [1.03-1.10],0.0001671865105333
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23646,111,1.37 [1.09-1.73],0.007212221216778
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14722,185,1.06 [0.87-1.28],0.5593766379987759
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14706,169,1.68 [1.41-2.01],1.0301245621398284e-08
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Hypotension,23728,1243,1.08 [1.00-1.16],0.049278195566225
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22796,118,0.85 [0.66-1.09],0.1991706483115086
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22199,2748,1.06 [1.00-1.11],0.0328620531215984
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23441,658,1.06 [0.96-1.17],0.2704438506471854
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,18998,417,1.28 [1.13-1.45],8.041781148627572e-05
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23142,1066,1.06 [0.98-1.15],0.1511283344587118
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",20377,926,1.08 [0.99-1.17],0.0888897956595833
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23716,223,1.10 [0.93-1.30],0.2770621602441239
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23823,375,1.11 [0.97-1.27],0.1147637732396881
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Oesophageal varices,22432,71,1.27 [0.95-1.70],0.1131395643866053
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other aneurysm,22467,96,1.13 [0.87-1.47],0.3476168689687346
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,19067,486,1.07 [0.95-1.21],0.2484577812675527
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22505,134,1.34 [1.08-1.65],0.0072843697856362
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22655,284,1.11 [0.95-1.29],0.1886205860202251
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,18778,197,0.92 [0.76-1.12],0.4177985396266018
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22459,98,0.96 [0.74-1.24],0.7562833387228396
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22412,51,0.84 [0.58-1.22],0.3681896931788602
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22281,91,1.06 [0.81-1.39],0.6559140460382711
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22469,108,1.19 [0.94-1.51],0.1550391282296139
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19836,1255,1.04 [0.96-1.12],0.3295762509407101
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22551,66,1.32 [0.97-1.78],0.0739190951429473
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22943,572,1.17 [1.06-1.30],0.0025902625331606
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23227,364,1.08 [0.95-1.24],0.2407321297560009
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22862,672,1.07 [0.97-1.19],0.1572773936777338
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,12040,375,1.09 [0.95-1.25],0.2206514444777987
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22851,529,1.25 [1.12-1.39],5.520579491218163e-05
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22718,357,0.95 [0.82-1.09],0.4612220802926701
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23365,502,1.08 [0.97-1.22],0.1648855730228538
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23812,715,1.06 [0.96-1.16],0.2634320934808577
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,19050,469,1.02 [0.90-1.15],0.8040043924581989
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23225,362,1.07 [0.94-1.23],0.2902475937879014
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22414,224,1.08 [0.91-1.28],0.3866580803402926
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23425,747,1.03 [0.94-1.13],0.513418927360474
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23409,777,1.02 [0.93-1.12],0.6263079850214381
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22773,48,0.77 [0.52-1.14],0.1908946877989481
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22487,117,0.95 [0.74-1.21],0.6614916340101622
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23036,253,1.07 [0.91-1.26],0.4392465942006972
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22392,316,1.02 [0.88-1.18],0.7584730151679305
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Varicose veins,22745,384,0.99 [0.87-1.13],0.8725602280734256
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22389,74,0.88 [0.65-1.21],0.4337120853329502
CPA2,Carboxypeptidase A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23637,787,1.01 [0.92-1.11],0.851897676742124
CPA2,Carboxypeptidase A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23677,495,0.95 [0.85-1.07],0.4366447714679412
CPA2,Carboxypeptidase A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20524,969,1.01 [0.93-1.10],0.8721448452576208
CPA2,Carboxypeptidase A2,Chapter V Mental and behavioural disorders,Any mental disorder,23189,3634,1.01 [0.97-1.06],0.5562638492130383
CPA2,Carboxypeptidase A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23614,585,0.93 [0.84-1.04],0.2007812958302994
CPA2,Carboxypeptidase A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20730,1175,1.00 [0.92-1.08],0.9366995609314824
CPA2,Carboxypeptidase A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19638,83,1.08 [0.81-1.43],0.6020176756674305
CPA2,Carboxypeptidase A2,Chapter V Mental and behavioural disorders,Smoking dependency,23227,1531,1.02 [0.96-1.09],0.4882149495811623
CPA2,Carboxypeptidase A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21424,1869,1.01 [0.95-1.08],0.6654195316280692
CPA2,Carboxypeptidase A2,Chapter V Mental and behavioural disorders,Vascular dementia,23366,152,1.24 [1.01-1.52],0.0408061161045936
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Alzheimer disease,23874,296,1.14 [0.98-1.33],0.0821941285483006
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",15866,58,0.81 [0.56-1.16],0.2520951937433451
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Bell's palsy,22501,75,1.09 [0.81-1.47],0.5498259304937612
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22770,344,0.97 [0.84-1.11],0.6423568308030511
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Cerebral cysts,23467,237,1.10 [0.93-1.30],0.2529771438691609
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23789,368,1.03 [0.90-1.18],0.6910475767908606
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23363,58,1.21 [0.87-1.68],0.2686905543540199
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23855,73,1.13 [0.84-1.52],0.4285360813873856
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23324,94,0.98 [0.75-1.29],0.883388933931627
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Epilepsy,22258,287,1.02 [0.87-1.19],0.8479337868598488
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23339,1368,1.02 [0.95-1.10],0.5216797964075768
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23840,688,0.97 [0.87-1.07],0.519122451302303
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23325,2211,1.04 [0.99-1.10],0.1219702557861323
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23484,59,0.85 [0.60-1.21],0.3757969358856003
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Hemiplegia,23704,283,1.05 [0.90-1.22],0.564192790660367
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Hydrocephalus,23286,56,1.04 [0.74-1.48],0.8191878981167613
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23858,61,1.21 [0.87-1.68],0.24839414948686
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22447,21,0.71 [0.39-1.29],0.2620463694473901
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22519,93,0.97 [0.74-1.27],0.8243716680098915
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Memory loss,23203,121,0.98 [0.77-1.25],0.8914912339754404
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Migraine,22167,196,0.95 [0.78-1.15],0.5824444698684725
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23852,176,0.95 [0.78-1.16],0.6322764431564414
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Motor neuron disease,15973,152,0.93 [0.75-1.15],0.5064679006628088
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23762,64,1.12 [0.81-1.55],0.5025228327445452
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23407,981,1.04 [0.96-1.13],0.3597275329177674
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Neurological diseases,22559,3682,1.03 [0.98-1.07],0.2138202171462894
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23550,245,0.99 [0.84-1.17],0.8834583980321544
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22819,393,1.04 [0.91-1.18],0.5837992803013541
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23780,353,1.22 [1.07-1.39],0.0037068411688038
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18723,623,1.08 [0.98-1.20],0.1329715876270651
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23310,80,0.98 [0.73-1.31],0.8994116236482604
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23386,156,1.30 [1.07-1.59],0.0087261470633245
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23294,142,0.96 [0.77-1.19],0.6932381658599487
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22520,94,1.10 [0.84-1.43],0.4930868520352769
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Other headache syndromes,22009,38,1.02 [0.67-1.56],0.935143707773326
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Other neurological diseases,23756,526,1.08 [0.97-1.21],0.1643250787547253
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Other sleep disorders,22675,704,1.02 [0.92-1.12],0.7564869255957956
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Parkinson's disease,23853,538,0.97 [0.87-1.09],0.6546169093884351
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23257,27,1.31 [0.80-2.13],0.2833841985467104
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23875,52,0.77 [0.53-1.12],0.1751671009344771
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Sleep apnoea,23574,634,1.02 [0.92-1.13],0.7038755212726298
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23485,58,0.74 [0.52-1.06],0.1053811392522919
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23857,177,0.88 [0.72-1.07],0.2012922667200872
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22460,34,0.93 [0.59-1.47],0.7614886612149968
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23874,299,1.15 [0.99-1.33],0.06851822204508
CPA2,Carboxypeptidase A2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23335,148,1.28 [1.04-1.57],0.0199703145205256
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23321,85,0.93 [0.70-1.23],0.6036579326943915
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23526,303,1.01 [0.87-1.17],0.933945536520892
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23678,293,2.20 [1.93-2.50],1.6262818415638002e-33
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22998,44,0.72 [0.48-1.09],0.1206723811845138
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23016,62,0.88 [0.63-1.24],0.4722449758005645
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23781,44,0.94 [0.64-1.40],0.775302511609125
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23641,124,1.06 [0.84-1.34],0.6045962000353733
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2470,84,1.70 [1.35-2.15],8.313739904136156e-06
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3005,131,1.25 [1.04-1.51],0.0170534130087306
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23332,96,0.95 [0.73-1.25],0.722115518345585
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23628,996,1.29 [1.20-1.40],2.0474981684607827e-10
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23570,616,0.98 [0.88-1.09],0.7511946357843196
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23098,144,0.91 [0.73-1.13],0.399774243493634
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23800,577,1.01 [0.90-1.12],0.9071230678782412
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23872,66,1.08 [0.79-1.49],0.6187386917471911
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23730,507,1.03 [0.92-1.16],0.5988125207814894
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23836,319,1.21 [1.05-1.40],0.0079098684549538
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23786,150,0.90 [0.72-1.11],0.3218299745516701
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23031,77,1.09 [0.81-1.46],0.5823232631984789
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23040,86,0.88 [0.66-1.17],0.3801358934214747
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22997,43,0.94 [0.63-1.40],0.7551949578375866
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23781,680,1.08 [0.98-1.19],0.1341316374804014
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23282,181,0.87 [0.72-1.06],0.1801500556679715
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23253,30,0.94 [0.58-1.52],0.8034558538724346
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23614,97,1.20 [0.93-1.55],0.1653337523178293
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23746,229,1.21 [1.02-1.43],0.027472548626219
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23395,172,1.11 [0.91-1.36],0.2921082333225465
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23719,83,0.96 [0.72-1.28],0.7746629195102452
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23560,459,1.14 [1.01-1.28],0.0349640289006312
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23366,130,1.06 [0.85-1.33],0.6005696383173855
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22501,1800,1.08 [1.01-1.15],0.0159350429584053
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23715,198,1.20 [1.00-1.43],0.0525146691618156
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23860,149,1.02 [0.83-1.26],0.8475745140237538
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23373,419,0.97 [0.85-1.10],0.6217198713742546
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23583,66,1.39 [1.02-1.88],0.0346347189705948
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23861,55,1.20 [0.86-1.69],0.2842130690692621
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23032,78,1.04 [0.77-1.39],0.813689537622087
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23095,141,0.93 [0.74-1.16],0.4928393686780468
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22760,128,1.17 [0.93-1.47],0.1787127552855236
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23275,52,0.82 [0.56-1.19],0.2973233219637019
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22697,65,0.93 [0.66-1.30],0.6727210059679283
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23154,53,0.87 [0.60-1.27],0.4787571540024203
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23309,208,1.15 [0.96-1.37],0.1300636020120744
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23073,119,1.10 [0.87-1.39],0.4175580731934373
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22754,122,0.98 [0.77-1.25],0.8492327396108215
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22727,95,1.30 [1.00-1.68],0.0473618662245676
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22178,1477,1.04 [0.97-1.11],0.3047913865568853
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23012,58,1.04 [0.74-1.46],0.8247051745584372
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23627,391,0.98 [0.86-1.12],0.8092231252382673
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23306,70,1.10 [0.81-1.49],0.5547736064960971
CPA2,Carboxypeptidase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23404,168,1.01 [0.83-1.24],0.89275914467259
CPA2,Carboxypeptidase A2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23699,58,1.39 [1.00-1.92],0.0483110242085335
CPA2,Carboxypeptidase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23834,122,1.04 [0.82-1.31],0.7691831474748497
CPA2,Carboxypeptidase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23740,114,1.04 [0.81-1.32],0.7697663244030175
CPA2,Carboxypeptidase A2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23691,50,0.93 [0.64-1.35],0.6920200317097323
CPA2,Carboxypeptidase A2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23695,54,1.16 [0.82-1.64],0.4076628455761309
CPA2,Carboxypeptidase A2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23781,970,1.03 [0.95-1.12],0.4417089002243112
CPA2,Carboxypeptidase A2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23529,718,1.06 [0.96-1.17],0.2324757471533395
CPA2,Carboxypeptidase A2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22940,129,0.93 [0.74-1.18],0.5614305041187564
CPA2,Carboxypeptidase A2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22897,86,1.10 [0.83-1.45],0.5095007489540408
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23662,61,1.09 [0.78-1.52],0.6051463682617162
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23791,190,1.09 [0.90-1.31],0.3739420945551187
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23664,63,1.01 [0.73-1.40],0.9436393895887288
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,All influenza,21579,106,1.32 [1.03-1.68],0.026030095718825
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),21576,103,1.29 [1.01-1.65],0.0441774717169593
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),15651,107,0.98 [0.75-1.27],0.8657432890812322
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23769,267,0.95 [0.81-1.12],0.5452244668340498
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16643,1447,1.03 [0.96-1.10],0.4615321699237421
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16964,1420,1.03 [0.96-1.11],0.3573698057642552
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23490,151,0.93 [0.75-1.15],0.4894420388346335
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21569,96,0.85 [0.65-1.11],0.2351709172191978
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Bronchiectasis,20758,296,0.93 [0.80-1.09],0.3763532998409586
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20506,44,1.14 [0.78-1.66],0.5127331485225493
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23030,2568,1.01 [0.95-1.06],0.836685276845149
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22426,79,0.84 [0.62-1.14],0.2663566027863852
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22509,162,1.00 [0.81-1.23],0.9776952104260438
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23651,1307,0.98 [0.91-1.05],0.5198455043071327
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22486,139,0.94 [0.75-1.18],0.6203385107243431
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21864,5293,1.03 [1.00-1.07],0.0774349451842304
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22742,395,1.03 [0.91-1.18],0.6074860334039018
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Early onset COPD,22651,307,0.96 [0.83-1.11],0.609817358605559
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Emphysema,20808,346,0.89 [0.77-1.03],0.1105682005020411
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22939,337,0.99 [0.86-1.15],0.9283550049886048
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23626,2153,1.06 [1.00-1.12],0.0465192595503539
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22967,365,1.01 [0.88-1.15],0.918333209865992
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Later onset COPD,22804,1000,0.98 [0.90-1.06],0.6484781283647023
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23857,429,1.03 [0.91-1.16],0.6800966498496381
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Nasal polyp,22492,145,1.08 [0.87-1.34],0.4670840734676739
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23605,1004,1.08 [1.00-1.18],0.051569323802727
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23594,2202,1.03 [0.98-1.09],0.2603157501346773
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23220,873,1.01 [0.92-1.10],0.8601184771537168
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Other pleural conditions,21458,66,1.23 [0.90-1.68],0.1920266433056514
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23779,448,1.03 [0.91-1.16],0.6853084195059245
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23751,1392,1.03 [0.96-1.10],0.4710509600547122
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Pleural effusion,22516,1124,1.07 [0.99-1.15],0.0923432623906944
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Pleural plaque,21657,265,0.84 [0.72-1.00],0.044107329586895
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23362,1889,1.06 [1.00-1.12],0.0651262639622093
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23756,328,1.07 [0.92-1.23],0.3866210563513076
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Pneumothorax,21534,142,0.98 [0.79-1.22],0.8626528053402959
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Pollen allergy,23860,233,0.94 [0.79-1.12],0.4904693568931717
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23398,67,1.27 [0.94-1.72],0.1190504670657547
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,15599,55,0.70 [0.49-1.02],0.0626881660919554
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23587,986,1.09 [1.00-1.18],0.0440719340065722
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22616,269,0.96 [0.81-1.13],0.5950494619762272
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Viral pneumonia,21753,280,1.12 [0.96-1.30],0.1574809261853295
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23508,238,1.06 [0.90-1.25],0.5038103566796295
CPA2,Carboxypeptidase A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10404,117,1.17 [0.92-1.49],0.2002615257608098
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16693,91,0.90 [0.68-1.19],0.4591934801575534
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Acute appendicitis,23741,144,1.32 [1.07-1.63],0.0093107888032164
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Acute gastritis,18021,90,0.98 [0.74-1.29],0.8788707069261565
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,22523,204,1.18 [0.98-1.40],0.0747300517353189
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Acute peritonitis,23514,100,1.52 [1.19-1.93],0.0006871195389321
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22984,115,1.07 [0.85-1.36],0.5519118319652951
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Barrett oesophagus,18460,529,0.99 [0.88-1.11],0.8620450683161651
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22440,121,1.16 [0.92-1.46],0.2062863005498252
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23475,121,1.16 [0.92-1.46],0.2058971546223633
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Cholecystitis,22541,222,0.97 [0.81-1.15],0.7200599747709504
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Cholelithiasis,23102,783,1.01 [0.92-1.11],0.8774539310163602
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Chronic gastritis,18194,263,1.02 [0.87-1.20],0.7928065078293386
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22376,57,1.06 [0.76-1.49],0.7170757191040171
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23669,134,1.22 [0.98-1.51],0.0722579681768008
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Coeliac disease,22240,93,7.01 [5.75-8.54],4.686227866593335e-83
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Collagenous colitis,22436,49,1.01 [0.70-1.46],0.966086579646302
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23710,223,1.01 [0.85-1.21],0.8804912496607243
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Constipation,23710,1600,0.99 [0.93-1.06],0.8799741601635701
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Crohn disease,22477,90,1.32 [1.02-1.72],0.0366914164490947
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23537,65,1.22 [0.89-1.66],0.2227473320875739
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22463,76,1.48 [1.12-1.95],0.0061649549966918
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Dental caries,23224,224,0.99 [0.83-1.18],0.9082468990928364
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20212,1947,1.04 [0.98-1.10],0.2040412006367233
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Diseases of appendix,23773,176,1.26 [1.04-1.53],0.0163910015428986
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Diseases of liver,23737,868,1.18 [1.08-1.29],0.0001415169287641
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21878,3947,1.08 [1.03-1.12],0.0004849752867446
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23510,510,0.99 [0.88-1.11],0.8783289401605863
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23825,411,1.15 [1.01-1.30],0.0294556743817772
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23109,109,0.93 [0.72-1.20],0.5901293367320368
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22968,65,1.14 [0.83-1.57],0.4234513859252797
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23557,1410,1.22 [1.14-1.31],9.021046155264809e-09
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Diseases of tongue,22988,108,0.95 [0.73-1.22],0.6739586560254887
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23509,1190,1.08 [1.00-1.16],0.0541547932814128
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19658,3056,1.01 [0.97-1.06],0.6148017231447009
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,18199,268,1.23 [1.06-1.44],0.0072037525254309
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23760,210,1.17 [0.99-1.39],0.0734818795773623
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23800,47,0.91 [0.62-1.35],0.6534281051735442
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23026,157,1.32 [1.09-1.61],0.0051067004642797
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16783,181,0.96 [0.79-1.17],0.7029731914659321
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18361,430,0.93 [0.82-1.05],0.2487234285278718
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Gastric ulcer,18299,368,1.07 [0.93-1.22],0.3381823807466999
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20090,2159,1.04 [0.98-1.10],0.1570371443299557
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18532,601,1.13 [1.01-1.25],0.0258037255797559
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18260,8000,1.05 [1.02-1.08],0.0019797418912015
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,GI-bleeding,23319,1172,1.02 [0.94-1.10],0.6478372814491951
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23042,42,1.22 [0.82-1.79],0.3274710669105931
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17562,1231,1.00 [0.93-1.08],0.9206258958986824
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22953,84,1.14 [0.87-1.50],0.3500318681281763
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Hernia,21813,3548,1.00 [0.96-1.04],0.9702067709070742
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Impacted teeth,23803,44,0.90 [0.60-1.35],0.6067070824338077
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Impaction of intestines,16649,47,1.26 [0.88-1.81],0.2045340830845636
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Inguinal hernia,19906,1641,0.98 [0.91-1.04],0.4568829975952648
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",18464,199,0.96 [0.80-1.16],0.706323772623396
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16691,89,1.08 [0.82-1.43],0.5596271244398268
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22253,106,6.07 [5.05-7.29],3.1706500886396474e-82
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16875,273,0.98 [0.84-1.15],0.836108275405772
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23835,377,1.33 [1.17-1.51],8.008776997160924e-06
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23067,680,1.05 [0.95-1.16],0.2952542846468343
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23276,889,1.06 [0.98-1.16],0.1643318145292864
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18145,214,1.07 [0.89-1.27],0.4727228513766809
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Oesophagitis,18561,630,1.16 [1.05-1.29],0.0032400559091725
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23822,113,0.98 [0.77-1.25],0.8719040195918638
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,18343,78,1.18 [0.89-1.58],0.2498798340990265
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18027,1425,1.08 [1.01-1.16],0.0230337754616658
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22578,259,1.24 [1.06-1.45],0.007072430942804
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22443,124,0.94 [0.74-1.19],0.6143546611026542
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,18470,1868,1.09 [1.02-1.15],0.0068776432152724
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,22072,5470,1.03 [0.99-1.07],0.1003643978957058
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22949,178,1.03 [0.85-1.25],0.7548546501230285
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of liver,23562,693,1.24 [1.13-1.37],6.759056753059787e-06
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18669,738,1.00 [0.90-1.10],0.9310211804144312
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22462,143,1.24 [1.01-1.53],0.0420123572526217
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23752,338,1.06 [0.92-1.22],0.4351352283899271
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18731,800,1.12 [1.02-1.22],0.0192599596979092
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23331,1184,1.02 [0.94-1.10],0.6457230087812924
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23178,178,1.01 [0.83-1.22],0.9438330983901372
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18240,1638,0.99 [0.93-1.06],0.7777896754126556
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19808,1877,1.13 [1.07-1.20],3.7551864995507086e-05
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22967,98,1.24 [0.97-1.59],0.0903317356143511
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23166,779,1.05 [0.96-1.15],0.2948908364933027
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16954,352,1.01 [0.88-1.16],0.9087637405037204
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23791,57,0.94 [0.66-1.34],0.7350779629119221
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17078,476,1.06 [0.94-1.20],0.30964445443296
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22311,164,1.13 [0.92-1.39],0.238441265397588
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23861,42,0.75 [0.49-1.14],0.1762495219039744
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23007,105,0.87 [0.67-1.13],0.3020496586447759
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Toxic colitis,22433,46,1.03 [0.70-1.51],0.8731727669663514
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18230,299,0.90 [0.77-1.05],0.1873528168092451
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22533,146,0.93 [0.75-1.16],0.5412885923189804
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22510,123,0.85 [0.66-1.08],0.1872643175284598
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Umbilical hernia,18637,372,1.02 [0.89-1.16],0.8241019593897937
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16758,156,0.98 [0.79-1.20],0.8214394904718768
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Ventral hernia,18529,264,0.96 [0.82-1.13],0.6325041197234383
CPA2,Carboxypeptidase A2,Chapter XI Diseases of the digestive system,Volvulus,16675,73,1.01 [0.74-1.38],0.9357989326956526
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23801,334,1.05 [0.91-1.21],0.5194806048548457
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23553,67,0.84 [0.60-1.16],0.2823528576768837
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21872,98,0.91 [0.69-1.19],0.4883397528790592
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23139,764,1.14 [1.04-1.25],0.0053757180157913
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22575,200,1.20 [1.00-1.44],0.0447037265917543
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22248,474,1.27 [1.13-1.42],4.754751363499247e-05
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23582,270,1.09 [0.94-1.28],0.2626222760592012
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23785,473,1.07 [0.95-1.21],0.2426058196973826
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23357,45,0.81 [0.54-1.22],0.3161447324103751
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22389,3190,1.06 [1.01-1.11],0.0096523524373543
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23427,407,0.96 [0.84-1.09],0.516191307175706
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23315,295,1.02 [0.88-1.19],0.7607694928485695
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23412,1037,1.12 [1.04-1.21],0.0045617894244052
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23865,30,0.80 [0.49-1.30],0.3666923098851123
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21797,23,1.30 [0.77-2.20],0.3201585346327077
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23078,58,0.78 [0.55-1.10],0.1547152928387542
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23577,265,1.09 [0.93-1.28],0.2831371876200353
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22259,485,1.00 [0.88-1.13],0.9667908283110784
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21854,80,1.06 [0.79-1.42],0.6956154130568025
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23808,82,1.12 [0.85-1.48],0.4286824512822204
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22595,220,1.32 [1.11-1.56],0.0012293734132545
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23705,219,1.02 [0.86-1.21],0.8312223428292671
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23383,71,1.25 [0.93-1.67],0.1431049017811691
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21841,67,1.03 [0.75-1.42],0.8585617699010366
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23420,1646,1.10 [1.04-1.18],0.0024819173933362
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22300,526,1.03 [0.91-1.15],0.6603842159533674
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21857,83,1.05 [0.79-1.40],0.7182466864919841
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23784,298,0.99 [0.85-1.16],0.9265281740619098
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23366,54,0.99 [0.69-1.40],0.9428927197388396
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23748,262,1.01 [0.86-1.19],0.8750263037694781
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23820,353,1.05 [0.91-1.20],0.5195896160141371
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21865,91,0.94 [0.71-1.24],0.6623447089058379
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22045,271,0.92 [0.78-1.08],0.3070361227823963
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23813,346,1.05 [0.91-1.21],0.526328067908826
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22048,274,1.32 [1.14-1.53],0.0001721820011492
CPA2,Carboxypeptidase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23850,124,1.01 [0.80-1.27],0.9291309450971972
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20604,92,1.13 [0.87-1.48],0.3572009022861945
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21770,4785,1.02 [0.98-1.06],0.3719624487780022
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20366,3381,1.00 [0.96-1.05],0.9877625755828024
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20585,73,1.12 [0.83-1.52],0.4546901471952652
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20961,153,1.11 [0.90-1.37],0.316516768053262
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20952,144,1.01 [0.82-1.26],0.903455634922701
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23672,68,1.12 [0.82-1.52],0.4865992466411093
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20887,79,1.16 [0.87-1.54],0.3117878235764234
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17856,871,0.94 [0.86-1.03],0.2072065344390231
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23756,151,1.10 [0.89-1.36],0.3890031193184891
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21081,273,1.00 [0.85-1.17],0.964519183227176
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20296,6257,1.00 [0.97-1.04],0.8787170416876324
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22809,92,1.00 [0.76-1.31],0.9835176571205186
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20679,167,1.01 [0.83-1.24],0.9017677218184714
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20950,438,0.99 [0.87-1.13],0.9069185704807936
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23045,2237,1.01 [0.95-1.06],0.8110745161799995
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20879,367,0.92 [0.80-1.06],0.2448584295711829
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20566,54,1.03 [0.72-1.47],0.8670256710533173
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20606,94,0.80 [0.60-1.06],0.1242385158830665
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23554,30,0.83 [0.51-1.35],0.4618695192820752
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18454,1469,1.05 [0.98-1.12],0.1783701850731739
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17964,979,1.16 [1.07-1.26],0.0003708756807501
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23734,965,1.16 [1.07-1.26],0.0002407775148129
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,17034,49,1.26 [0.88-1.80],0.2147320082987048
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),17064,79,0.95 [0.71-1.28],0.7397458809499207
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20784,272,1.04 [0.89-1.22],0.6203400306228479
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17619,634,1.02 [0.92-1.13],0.7339577418183805
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20851,43,1.16 [0.79-1.71],0.4505924293043828
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21340,532,1.05 [0.94-1.18],0.3597496671452518
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21079,271,0.98 [0.84-1.15],0.8496785082290891
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17577,592,1.02 [0.91-1.13],0.7697326800013373
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20578,66,0.99 [0.71-1.37],0.9506824994533594
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20566,54,1.01 [0.70-1.44],0.9711632279084944
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22813,96,1.12 [0.87-1.44],0.3962998723220398
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23585,868,1.03 [0.95-1.13],0.4683028243297608
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23120,403,1.04 [0.91-1.18],0.5774592318424279
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23793,289,1.04 [0.89-1.21],0.6358031872390388
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18877,1892,0.98 [0.93-1.05],0.6092450633279978
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,17037,52,0.77 [0.52-1.12],0.1688035300431596
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20594,82,0.74 [0.55-1.00],0.0531676410227552
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,17040,55,1.07 [0.76-1.53],0.6905702065215569
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),17031,46,0.79 [0.53-1.18],0.2554762149192246
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22903,186,1.09 [0.91-1.32],0.358037784318749
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22878,161,0.98 [0.80-1.20],0.840458588158914
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23840,86,0.94 [0.71-1.25],0.6653223487558813
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22341,1533,1.05 [0.99-1.12],0.1258788740789025
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20580,68,0.75 [0.53-1.04],0.0845927933837782
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),17025,40,0.82 [0.53-1.25],0.3456873643318215
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21430,622,1.04 [0.94-1.16],0.4325889783829998
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18704,1719,0.99 [0.92-1.05],0.6485252882768205
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23578,54,0.65 [0.45-0.95],0.0249150521634558
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23857,61,0.79 [0.56-1.12],0.180300974433518
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20593,81,0.82 [0.61-1.11],0.2057828088790577
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21501,989,0.94 [0.87-1.02],0.1601399280290496
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20608,96,0.95 [0.73-1.25],0.7236037024744553
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18189,1204,0.95 [0.88-1.02],0.1750272520087834
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22802,85,1.20 [0.91-1.58],0.1859056309309928
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20557,45,0.87 [0.58-1.30],0.501747613689082
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20920,112,0.91 [0.71-1.17],0.454293313801723
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21015,503,0.93 [0.82-1.04],0.2116550102533322
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23720,196,0.92 [0.76-1.11],0.3959054457838104
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21293,485,1.04 [0.93-1.17],0.5070339982661523
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23802,283,1.02 [0.88-1.19],0.7951943700217893
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23860,39,1.01 [0.66-1.53],0.9660863227200224
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20665,153,1.03 [0.84-1.28],0.7632433425172298
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19573,580,1.04 [0.93-1.15],0.5246983528988047
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20997,485,0.96 [0.85-1.08],0.4882896955583015
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20844,332,0.92 [0.79-1.06],0.2583460455338395
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",17016,31,1.11 [0.70-1.75],0.6545039587194179
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19250,2265,1.04 [0.98-1.09],0.2050105390290837
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17438,453,1.00 [0.88-1.13],0.9979853354080648
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23689,165,0.89 [0.73-1.10],0.2851285293376093
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23802,48,0.91 [0.62-1.34],0.6384311685814039
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21876,46,1.23 [0.86-1.77],0.2624774441742688
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,17048,63,0.80 [0.57-1.13],0.2097788671880991
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20897,89,0.91 [0.69-1.20],0.5011608142772793
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,17282,297,1.04 [0.90-1.21],0.5884494046676397
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20792,280,1.07 [0.91-1.24],0.4238206804208291
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21025,217,1.04 [0.88-1.24],0.6309727207890599
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20902,94,1.01 [0.77-1.32],0.9538542362980412
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18952,31,1.20 [0.77-1.88],0.4219552328355314
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23861,40,1.09 [0.72-1.63],0.6907742684929895
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21045,533,1.01 [0.91-1.14],0.8110319992559762
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],23545,21,1.13 [0.65-1.98],0.6581844657591408
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22792,2280,0.95 [0.90-1.01],0.0801602343483861
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20617,105,0.99 [0.76-1.28],0.9126324163789706
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21316,508,1.04 [0.93-1.17],0.4869114749294068
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22813,197,0.92 [0.76-1.11],0.3674182131123824
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20938,130,1.06 [0.84-1.32],0.6380361498609257
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22123,1315,1.02 [0.95-1.10],0.5288478901423449
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21630,822,0.99 [0.91-1.09],0.8558708389034608
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20555,43,0.75 [0.49-1.14],0.1824814926801829
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23562,38,1.07 [0.71-1.64],0.7383878863852374
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20633,121,1.08 [0.86-1.37],0.5095285719796839
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20534,22,1.60 [0.96-2.65],0.0695709533571669
CPA2,Carboxypeptidase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),17045,60,0.68 [0.48-0.98],0.0371049808870691
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22872,1876,1.24 [1.17-1.31],9.6116875955663e-13
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23404,412,1.07 [0.94-1.21],0.3299954592813517
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23133,141,1.15 [0.93-1.43],0.1992671048243409
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22540,1544,1.40 [1.32-1.50],2.4276559526587078e-26
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23623,85,1.81 [1.41-2.32],3.032213016333645e-06
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23597,356,1.16 [1.01-1.33],0.0302428813483144
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Cystitis,20997,211,0.89 [0.74-1.07],0.2135096305237322
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Dialysis,21098,102,2.27 [1.83-2.82],1.2335054171024908e-13
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22593,3332,0.98 [0.93-1.02],0.3546030927105851
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21504,5597,1.06 [1.02-1.10],0.0012980988120014
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23641,103,1.97 [1.58-2.46],1.9471098542116222e-09
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,19469,208,0.98 [0.82-1.18],0.8399496309487003
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21105,372,1.28 [1.12-1.46],0.0002807370681261
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21878,2617,0.98 [0.93-1.03],0.4400556896637833
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19495,234,0.94 [0.79-1.12],0.5167846954812065
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20865,79,0.90 [0.66-1.22],0.489873427388381
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19369,108,0.98 [0.76-1.26],0.8773525579035559
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23863,61,0.86 [0.61-1.20],0.370581229564027
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23869,57,0.93 [0.65-1.32],0.6882726159963598
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23035,2249,1.03 [0.97-1.08],0.3625415591994597
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21740,954,1.04 [0.95-1.13],0.3782553425674421
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23802,561,1.14 [1.03-1.27],0.0140432837243429
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19571,310,1.11 [0.96-1.29],0.1563973855805341
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19542,281,0.95 [0.82-1.12],0.5609307957458413
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19496,235,0.93 [0.78-1.10],0.381232130123081
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23859,46,1.58 [1.11-2.24],0.0106710868052105
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22323,1537,1.07 [1.00-1.14],0.0507352585264004
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21150,417,1.26 [1.11-1.42],0.0003299067022511
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23431,190,1.16 [0.96-1.39],0.1263250788586096
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23598,60,1.34 [0.97-1.86],0.0729505171421865
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19527,266,1.00 [0.85-1.18],0.9736755150116873
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23571,2838,1.22 [1.17-1.28],6.564598086032706e-17
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",20807,74,1.15 [0.85-1.55],0.3690447000698826
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21153,157,1.38 [1.13-1.68],0.0015511160879355
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23070,78,0.94 [0.70-1.26],0.6688609901979762
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21078,292,0.95 [0.82-1.11],0.5352543191097501
CPA2,Carboxypeptidase A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23521,529,1.06 [0.95-1.19],0.2915792070934379
